254 related articles for article (PubMed ID: 32411571)
1. Amyloid beta peptide-degrading microbial enzymes and its implication in drug design.
Dhanavade MJ; Sonawane KD
3 Biotech; 2020 Jun; 10(6):247. PubMed ID: 32411571
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
3. Homology modeling, molecular docking and MD simulation studies to investigate role of cysteine protease from Xanthomonas campestris in degradation of Aβ peptide.
Dhanavade MJ; Jalkute CB; Barage SH; Sonawane KD
Comput Biol Med; 2013 Dec; 43(12):2063-70. PubMed ID: 24290922
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of selective amyloid-β degrading enzymes in Alzheimer's disease.
Żukowska J; Moss SJ; Subramanian V; Acharya KR
FEBS J; 2023 Aug; ():. PubMed ID: 37622248
[TBL] [Abstract][Full Text] [Related]
5. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
6. Structural significance of Neprylysin from Streptococcus suis GZ1 in the degradation of Aβ peptides, a causative agent in Alzheimer's disease.
Kamble S; Barale S; Dhanavade M; Sonawane K
Comput Biol Med; 2021 Sep; 136():104691. PubMed ID: 34343891
[TBL] [Abstract][Full Text] [Related]
7. Insights into the molecular interactions between aminopeptidase and amyloid beta peptide using molecular modeling techniques.
Dhanavade MJ; Sonawane KD
Amino Acids; 2014 Aug; 46(8):1853-66. PubMed ID: 24729013
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a possible role of Stigmatella aurantiaca ACE in Aβ peptide degradation: a molecular modeling approach.
Jalkute CB; Sonawane KD
J Mol Microbiol Biotechnol; 2015; 25(1):26-36. PubMed ID: 25677850
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo
Portelius E; Mattsson N; Pannee J; Zetterberg H; Gisslén M; Vanderstichele H; Gkanatsiou E; Crespi GA; Parker MW; Miles LA; Gobom J; Blennow K
Mol Neurodegener; 2017 Feb; 12(1):18. PubMed ID: 28219449
[TBL] [Abstract][Full Text] [Related]
10. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
Higuchi M; Iwata N; Saido TC
Biochim Biophys Acta; 2005 Aug; 1751(1):60-7. PubMed ID: 16054018
[TBL] [Abstract][Full Text] [Related]
11. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
[TBL] [Abstract][Full Text] [Related]
12. Experimental approaches for altering the expression of Abeta-degrading enzymes.
Loeffler DA
J Neurochem; 2023 Mar; 164(6):725-763. PubMed ID: 36633092
[TBL] [Abstract][Full Text] [Related]
13. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
14. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
15. Restored degradation of the Alzheimer's amyloid-beta peptide by targeting amyloid formation.
Crouch PJ; Tew DJ; Du T; Nguyen DN; Caragounis A; Filiz G; Blake RE; Trounce IA; Soon CP; Laughton K; Perez KA; Li QX; Cherny RA; Masters CL; Barnham KJ; White AR
J Neurochem; 2009 Mar; 108(5):1198-207. PubMed ID: 19141082
[TBL] [Abstract][Full Text] [Related]
16. Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease?
Liu Z; Zhu H; Fang GG; Walsh K; Mwamburi M; Wolozin B; Abdul-Hay SO; Ikezu T; Leissring MA; Qiu WQ
J Alzheimers Dis; 2012; 29(2):329-40. PubMed ID: 22232014
[TBL] [Abstract][Full Text] [Related]
17. Metallostasis and amyloid β-degrading enzymes.
Grasso G; Giuffrida ML; Rizzarelli E
Metallomics; 2012 Aug; 4(9):937-49. PubMed ID: 22832870
[TBL] [Abstract][Full Text] [Related]
18. Amyloid β peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Aβ-mediated toxicity in vitro.
Shropshire TD; Reifert J; Rajagopalan S; Baker D; Feinstein SC; Daugherty PS
Biol Chem; 2014 Jan; 395(1):109-18. PubMed ID: 23989112
[TBL] [Abstract][Full Text] [Related]
19. Emerging beta-amyloid therapies for the treatment of Alzheimer's disease.
Conway KA; Baxter EW; Felsenstein KM; Reitz AB
Curr Pharm Des; 2003; 9(6):427-47. PubMed ID: 12570807
[TBL] [Abstract][Full Text] [Related]
20.
Jean L; Brimijoin S; Vaux DJ
J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
